x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Life Science Rundown

The Life Science Rundown is a podcast for life science professionals hosted by The FDA Group. We dive deep into topics across the RA/QA/Clinical space, covering news, exploring trends, and picking the brains of expert guests.

science life sciences

All Episodes

00:52:32

Motivating Technical Teams in the Life Sciences: A...

The Life Science Rundown ·

2023/10/09

The FDA Group’s CEO, Nick Capman, sits down with Rick Beatty, Chief Science Officer and Senior VP of Quality and Regulatory at Robinson Pharma, the largest industry contract manufacturer in the U.S. They discuss: » Leadership philosophy, particularly the importance of focusing on employees’ success as a pathway to organizational achievement. » Rick's shift in leadership approach after training with Marshall Goldsmith, moving from a self-centered to a people-centered approach. » The generational

en

00:40:30

Cross-Cultural Pharma: Mike Martin's Experiences from...

The Life Science Rundown ·

2023/08/14

The FDA Group’s CEO, Nick Capman, sits down with CAI's CEO, Mike Martin, BSME, MBA, PE, whose roles have spanned from designing facilities and systems to CEO, including experiences in device manufacturing, global project management, and regulatory insights. They discuss: » Mike's personal journey from growing up in Southern Indiana with a passion for math and science to leading major pharmaceutical projects around the world. » The importance of servant leadership in the pharmaceutical

en

00:49:06

Courageous Leadership to Reinvent Our Healthcare System

The Life Science Rundown ·

2023/07/27

The FDA Group's CEO, Nick Capman speaks with Cheryl Blasie, Ph.D., a healthcare consultant and advocate whose roles have spanned from entry-level Ph.D. Research Scientist to Vice President and Head of Quality at biotech and biopharma companies, including Program Management, Business Operations, and Patient Advocacy. They discuss: » Cheryl's personal journey from being a biotech industry veteran to becoming a healthcare advocate, driven by her own health challenges. » The need for courageous

en

00:30:03

The Critical Role of 'Hyper-Targeting' in Rare...

The Life Science Rundown ·

2023/07/14

The FDA Group’s CEO Nick Capman sits down with Dan Donovan, an expert in rare disease drug development, to explore the unique challenges and new opportunities presented in the rare disease space. They discuss: » The critical role of patient advocates and caregivers in conducting successful studies and applications for bringing a rare disease drug to market. » The financial and resource challenges faced in the field of rare diseases and drug development. » The potential for individuals to

en

00:36:34

A Journey into Life Sciences Investment: Strategies,...

The Life Science Rundown ·

2023/06/01

The FDA Group’s CEO Nick Capman sits down with seasoned investor Salvatore Buscemi to delve into the intricacies of investment in early-stage life science and device companies. They highlight key aspects such as: » The definition and role of 'family offices' in life science investments. » The importance of investors being prepared to lose their investment due to potential risks, highlighting that these investors should be aware of who they're investing alongside. » The mistakes

en

00:35:40

Navigating Risk Management in Medical Devices with...

The Life Science Rundown ·

2023/05/15

The FDA Group's CEO, Nick Capman sits down with Brian Dense, a medical device consultant with over 30 years of experience across several parts of the industry, to discuss risk management for medical devices, emphasizing key points such as: » The importance of risk management in the medical device industry as it forms the basis of regulations and ensures safe and cost-effective products. » Different markets, including the European Union, Canada, and the United States, and their specific

en

00:30:27

The DEA, FDA & Controlled Substances: An Insider's...

The Life Science Rundown ·

2023/04/26

The FDA Group's CEO, Nick Capman sits down with former DEA agent Dennis Wichern to discuss the vital role of compliance for pharmaceutical companies dealing with controlled substances and the significance of adhering to DEA regulations. Key discussion points include: » The importance of strong compliance programs, record-keeping, and suspicious order monitoring systems, especially in light of the nationwide opioid lawsuits. » Common issues faced by DEA registrants, such as poor record-keeping

en

00:38:07

A Deep Dive into Medical Device Regulatory Strategy...

The Life Science Rundown ·

2023/04/11

The FDA Group's CEO, Nick Capman, sits down with Regulatory Attorney Christine P. Bump to discuss the current regulatory landscape for medical devices and the importance of developing a thoughtful regulatory strategy. Discussion points include: » The three classifications of medical devices and the various regulatory submission types — each with different risk levels, required data, costs, and approval timelines. » The costs associated with FDA approval. » Why it's important to craft a

en

00:29:24

Lessons from a Medtech Entrepreneur: Ram Konduru on...

The Life Science Rundown ·

2023/04/03

The FDA Group's CEO, Nick Capman sits down with Ram Konduru, CEO of PrimeSoft Inc (North America & Europe) and Co-Founder of Coherence Health. Ram discusses his experience in leadership and management, highlighting the importance of having a common purpose and goal for a team. Ram and Nick also discuss the need for leaders to create strong bonds within their teams, provide opportunities for team members to bond, and be humble and relatable. Other discussion points include: » Ram’s personal

en

00:36:04

Unlocking Effective Leadership: A Conversation with...

The Life Science Rundown ·

2023/03/24

The FDA Group's CEO, Nick Capman sits down with David Marlin, President of MetaComet Systems, a company specializing in royalty automation software. David shares his background, thoughts on leadership and management, and the importance of working towards a common goal. He emphasizes the value of joining peer groups, vulnerability, trust, and using the Entrepreneurial Operating System (EOS). He credits the concept of "letting go of the vine" for reducing stress and improving overall

en

00:30:58

Leadership, Management, and Enhancing Quality of...

The Life Science Rundown ·

2023/03/09

The FDA Group's CEO, Nick Capman sits down with Dan Barker, CEO of Wikimotive, to explore perspectives on management and leadership. Dan shares his unique professional journey and dives into the importance of vulnerability and constant learning in leadership and management, as well as discussing other topics, including: How management can be the 'easy' side of the equation, with leadership being about ensuring management systems are built and executed effectively. Dan's non-typical career path,

en

00:22:32

Navigating the 510(k) Process: A Q&A with Regulatory...

The Life Science Rundown ·

2023/02/09

The FDA Group’s CEO, Nick Capman, sits down with Regulatory Consultant Trey Thorsen, MS, RAC, to answer some of the most frequently asked questions about navigating the 510(k) premarket notification process. Trey brings experience in Class I, II, and III devices, such as active implantables with MRI functionality, external therapeutic devices indicated for pain, devices that have software functionality, transvaginal catheter systems that evaluate fallopian tube patency, sterile and non-sterile wound

en

00:25:44

The Future of Life Science Talent Acquisition:...

The Life Science Rundown ·

2022/11/21

Earlier this year, Deloitte released its Global Life Sciences Outlook report, featuring a section devoted to "transforming the talent experience." The FDA Group's CEO, Nick Capman, sat down with Larry Stevens, RAC, to unpack some of Deloitte's findings and what they might mean for life science teams looking to innovate their workforce strategies and navigate a hyper-competitive specialized labor market. Read Deloitte's full report (PDF):

en

00:07:37

FDA Revives Its Proposed Quality Metrics Program for...

The Life Science Rundown ·

2022/04/18

The FDA Group's Nick Capman discusses the recent news that the FDA is once again returning to its quality metrics program for pharma manufacturers. The agency’s focus on quality metrics began in 2015 and continued with a heavily revised draft guidance on submitting metrics data, including quality-related complaints. The guidance led to two FDA pilot projects in 2018. In a new update, FDA stressed that additional quality data can help both the FDA and the supply chain, which needs to have a better

en

00:21:45

Inspection Alternatives Are Driving More FDA...

The Life Science Rundown ·

2022/02/14

Product sampling and remote records requests accounted for most import alerts and drug GMP warning letters over FDA's fiscal year 2021. They may play a key role post-pandemic. As remote records reviews conducted during the pandemic accounted for a growing share of warning letters, experts have advised the industry to prepare for remote FDA oversight to continue even after routine site inspections resume and the pandemic recedes. The FDA, which historically relied solely on on-site inspections as a

en

00:08:33

FDA's Domestic Biopharma Inspections Return to Normal

The Life Science Rundown ·

2021/08/05

For the first time since March 2020, the FDA’s inspections of US-based biopharma sites have returned to normal, according to FDA acting commissioner Janet Woodcock. “I’m pleased to say that as of this month, we’ve begun transitioning back to standard operations for domestic inspections while continuing to prioritize mission-critical work for foreign inspections,” Woodcock said. The return to normalcy will be welcomed by industry, which has grappled with a growing backlog of mostly surveillance

en

00:26:36

Quality Management Review: Benchmarking Quantitatively!

The Life Science Rundown ·

2021/07/02

The FDA Group’s CEO, Nick Capman, sits down with Tobias Kuners of Koenders, Managing Consultant at Tob Management, to discuss his integrated approach to implementing and interpreting qualitative and quantitative metrics in the GMP and non-GMP sides of a life science business. Read his full column in Pharmaceutical Online: https://www.pharmaceuticalonline.com/doc/quality-management-review-benchmarking-quantitatively-0001 Tobias has worked with Biogen, Ipsen, Thermo Fisher, Kite Pharma, and Danone,

en

00:31:08

Addressing FDA's Inspection Backlog with Mary...

The Life Science Rundown ·

2021/06/03

The FDA Group’s CEO, Nick Capman, sits down with Mary Denigan-Macauley, Director of Health Care in the Government Accountability Office (GAO) to understand the situation the FDA finds itself in with respect to a pandemic-induced inspection backlog, and what measures the agency may take to address it. Mary joined GAO in 2001, managing a diverse portfolio related to science and animal health for GAO’s Natural Resource and Environment team. This work covered cross-cutting topics such as foreign animal

en

00:08:02

FDA's Fraudulent Products Task Force and Operation...

The Life Science Rundown ·

2021/03/09

The FDA Group’s CEO, Nick Capman, discusses the federal effort to thwart COVID-19 vaccine scams. Read the full article on FDA.gov here. Need RA/QA/Clinical project or resourcing support? The FDA Group helps thousands of life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical

en

00:08:59

What to Expect for the FDA's Regulation of Medical...

The Life Science Rundown ·

2021/01/28

The FDA Group’s CEO, Nick Capman, breaks down the key points in a recent Morgan Lewis article laying out what to expect for the FDA's regulation of medical devices and digital health under the Biden administration. Read the full Morgan Lewis piece here. Need RA/QA/Clinical project or resourcing support? The FDA Group helps thousands of life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle,

en

64 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter